NCT00886002View on ClinicalTrials.gov

Comparison of Two Dosage Strengths of Transdermal Fentanyl Versus Transdermal Buprenorphine and Placebo in Acute Pain Models in Healthy Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

January 31, 2005

Conditions
Pain
Interventions
DRUG

Fentanyl; Buprenorphine; Naloxone

All Listed Sponsors
lead

Janssen-Cilag A.G., Switzerland

INDUSTRY

NCT00886002 - Comparison of Two Dosage Strengths of Transdermal Fentanyl Versus Transdermal Buprenorphine and Placebo in Acute Pain Models in Healthy Volunteers. | Biotech Hunter | Biotech Hunter